168 related articles for article (PubMed ID: 32098890)
1. Harnessing Population Pedigree Data and Machine Learning Methods to Identify Patterns of Familial Bladder Cancer Risk.
Hanson HA; Leiser CL; O'Neil B; Martin C; Gupta S; Smith KR; Dechet C; Lowrance WT; Madsen MJ; Camp NJ
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):918-926. PubMed ID: 32098890
[TBL] [Abstract][Full Text] [Related]
2. Describing patterns of familial cancer risk in subfertile men using population pedigree data.
Ramsay JM; Madsen MJ; Horns JJ; Hanson HA; Camp NJ; Emery BR; Aston KI; Ferlic E; Hotaling JM
Hum Reprod; 2024 Apr; 39(4):822-833. PubMed ID: 38383051
[TBL] [Abstract][Full Text] [Related]
3. Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case-Control Study.
Martin C; Leiser CL; O'Neil B; Gupta S; Lowrance WT; Kohlmann W; Greenberg S; Pathak P; Smith KR; Hanson HA
J Natl Cancer Inst; 2018 May; 110(5):527-533. PubMed ID: 29228305
[TBL] [Abstract][Full Text] [Related]
4. Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland.
Matikaine MP; Pukkala E; Schleutker J; Tammela TL; Koivisto P; Sankila R; Kallioniemi OP
Cancer Causes Control; 2001 Apr; 12(3):223-30. PubMed ID: 11405327
[TBL] [Abstract][Full Text] [Related]
5. Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database.
Hanson HA; Leiser CL; Madsen MJ; Gardner J; Knight S; Cessna M; Sweeney C; Doherty JA; Smith KR; Bernard PS; Camp NJ
Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):807-815. PubMed ID: 32098891
[TBL] [Abstract][Full Text] [Related]
6. Familial Urinary Bladder Cancer with Other Cancers.
Yu H; Hemminki O; Försti A; Sundquist K; Hemminki K
Eur Urol Oncol; 2018 Dec; 1(6):461-466. PubMed ID: 31158089
[TBL] [Abstract][Full Text] [Related]
7. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden.
Hemminki K; Li X
Gut; 2003 Apr; 52(4):592-6. PubMed ID: 12631675
[TBL] [Abstract][Full Text] [Related]
8. Familial aggregation of bladder cancer stratified by smoking status.
Kramer AA; Graham S; Burnett WS; Nasca P
Epidemiology; 1991 Mar; 2(2):145-8. PubMed ID: 1932313
[TBL] [Abstract][Full Text] [Related]
9. Familial Clustering of Erosive Hand Osteoarthritis in a Large Statewide Cohort.
Kazmers NH; Meeks HD; Novak KA; Yu Z; Fulde GL; Thomas JL; Barker T; Jurynec MJ
Arthritis Rheumatol; 2021 Mar; 73(3):440-447. PubMed ID: 32940959
[TBL] [Abstract][Full Text] [Related]
10. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families.
Read J; Symmons J; Palmer JM; Montgomery GW; Martin NG; Hayward NK
Fam Cancer; 2016 Oct; 15(4):651-63. PubMed ID: 27108303
[TBL] [Abstract][Full Text] [Related]
12. Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden.
Bermejo JL; Sundquist J; Hemminki K
Int J Cancer; 2009 May; 124(9):2166-71. PubMed ID: 19117061
[TBL] [Abstract][Full Text] [Related]
13. Establishing a familial basis for papillary thyroid carcinoma using the Utah Population Database.
Oakley GM; Curtin K; Pimentel R; Buchmann L; Hunt J
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1171-4. PubMed ID: 24092278
[TBL] [Abstract][Full Text] [Related]
14. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
Goldgar DE; Easton DF; Cannon-Albright LA; Skolnick MH
J Natl Cancer Inst; 1994 Nov; 86(21):1600-8. PubMed ID: 7932824
[TBL] [Abstract][Full Text] [Related]
15. Familial aggregation of early-onset cancers.
Heikkinen SMM; Madanat-Harjuoja LM; Seppä KJM; Rantanen ME; Hirvonen EM; Malila NK; Pitkäniemi JM
Int J Cancer; 2020 Apr; 146(7):1791-1799. PubMed ID: 31199509
[TBL] [Abstract][Full Text] [Related]
16. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma.
Abdel-Rahman MH; Pilarski R; Ezzat S; Sexton J; Davidorf FH
Fam Cancer; 2010 Sep; 9(3):431-8. PubMed ID: 20157784
[TBL] [Abstract][Full Text] [Related]
17. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families.
Dong C; Hemminki K
Int J Cancer; 2001 Apr; 92(1):144-50. PubMed ID: 11279618
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study).
Andrieu N; Launoy G; Guillois R; Ory-Paoletti C; Gignoux M
Gut; 2004 Sep; 53(9):1322-8. PubMed ID: 15306593
[TBL] [Abstract][Full Text] [Related]
19. Familial testicular cancer and second primary cancers in testicular cancer patients by histological type.
Dong C; Lönnstedt I; Hemminki K
Eur J Cancer; 2001 Oct; 37(15):1878-85. PubMed ID: 11576844
[TBL] [Abstract][Full Text] [Related]
20. Familial renal cell carcinoma from the Swedish Family-Cancer Database.
Liu H; Sundquist J; Hemminki K
Eur Urol; 2011 Nov; 60(5):987-93. PubMed ID: 21621909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
